474 related articles for article (PubMed ID: 31488157)
1. Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma.
Zhao H; Chen L; Yang T; Feng YL; Vaziri ND; Liu BL; Liu QQ; Guo Y; Zhao YY
J Transl Med; 2019 Sep; 17(1):302. PubMed ID: 31488157
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation.
Liu JR; Miao H; Deng DQ; Vaziri ND; Li P; Zhao YY
Cell Mol Life Sci; 2021 Feb; 78(3):909-922. PubMed ID: 32965514
[TBL] [Abstract][Full Text] [Related]
3. Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling.
Tan YQ; Wang YN; Feng HY; Guo ZY; Li X; Nie XL; Zhao YY
Free Radic Biol Med; 2022 May; 184():30-41. PubMed ID: 35367341
[TBL] [Abstract][Full Text] [Related]
4. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
[TBL] [Abstract][Full Text] [Related]
5. The aryl hydrocarbon receptor in the crossroad of signalling networks with therapeutic value.
Roman ÁC; Carvajal-Gonzalez JM; Merino JM; Mulero-Navarro S; Fernández-Salguero PM
Pharmacol Ther; 2018 May; 185():50-63. PubMed ID: 29258844
[TBL] [Abstract][Full Text] [Related]
6. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
[TBL] [Abstract][Full Text] [Related]
7. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
[TBL] [Abstract][Full Text] [Related]
8. Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor.
Yang T; Feng YL; Chen L; Vaziri ND; Zhao YY
Crit Rev Toxicol; 2019 May; 49(5):445-460. PubMed ID: 31433724
[TBL] [Abstract][Full Text] [Related]
9. Diet-Host-Microbiota Interactions Shape Aryl Hydrocarbon Receptor Ligand Production to Modulate Intestinal Homeostasis.
Han H; Safe S; Jayaraman A; Chapkin RS
Annu Rev Nutr; 2021 Oct; 41():455-478. PubMed ID: 34633858
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells.
Luzzani GA; Callero MA; Kuruppu AI; Trapani V; Flumian C; Todaro L; Bradshaw TD; Loaiza Perez AI
J Cell Biochem; 2017 Dec; 118(12):4526-4535. PubMed ID: 28471540
[TBL] [Abstract][Full Text] [Related]
11. The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis.
Huang W; Rui K; Wang X; Peng N; Zhou W; Shi X; Lu L; Hu D; Tian J
J Autoimmun; 2023 Jul; 138():103049. PubMed ID: 37229809
[TBL] [Abstract][Full Text] [Related]
12. The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?
Mo Y; Lu Z; Wang L; Ji C; Zou C; Liu X
Front Cell Dev Biol; 2020; 8():589752. PubMed ID: 33415104
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
[TBL] [Abstract][Full Text] [Related]
14. Maternal Tryptophan Supplementation Protects Adult Rat Offspring against Hypertension Programmed by Maternal Chronic Kidney Disease: Implication of Tryptophan-Metabolizing Microbiome and Aryl Hydrocarbon Receptor.
Hsu CN; Lin IC; Yu HR; Huang LT; Tiao MM; Tain YL
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604820
[TBL] [Abstract][Full Text] [Related]
15. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
[TBL] [Abstract][Full Text] [Related]
16. Indole scaffolds as a promising class of the aryl hydrocarbon receptor ligands.
Dvořák Z; Poulíková K; Mani S
Eur J Med Chem; 2021 Apr; 215():113231. PubMed ID: 33582577
[TBL] [Abstract][Full Text] [Related]
17. The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function.
Park R; Madhavaram S; Ji JD
Cells; 2020 Oct; 9(10):. PubMed ID: 33066667
[TBL] [Abstract][Full Text] [Related]
18. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals.
Denison MS; Nagy SR
Annu Rev Pharmacol Toxicol; 2003; 43():309-34. PubMed ID: 12540743
[TBL] [Abstract][Full Text] [Related]
19. The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment.
Shinde R; McGaha TL
Trends Immunol; 2018 Dec; 39(12):1005-1020. PubMed ID: 30409559
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways.
Oesch-Bartlomowicz B; Huelster A; Wiss O; Antoniou-Lipfert P; Dietrich C; Arand M; Weiss C; Bockamp E; Oesch F
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9218-23. PubMed ID: 15972329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
